Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Taylor

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Antibiotics|May 1, 1986
A cryptic plasmid from Nocardia orientalis NRRL 2452, a vancomycin producerY K Oh, L R Fare, D P Taylor, et al.
Australian Veterinary Journal|June 28, 2017
Long-term control of olfactory neuroblastoma in a dog treated with surgery and radiation therapyE Gumpel, A S Moore, D J Simpson, et al.
The Journal of Antibiotics|April 1, 1993
Screening microbial metabolites for new drugs--theoretical and practical issuesG G Yarbrough, D P Taylor, R T Rowlands, et al.
Applied and Environmental Microbiology|July 1, 1983
Ethanol Production by Saccharomyces cerevisiae Immobilized in Hollow-Fiber Membrane BioreactorsD S Inloes, D P Taylor, S N Cohen, et al.
Journal of Medicinal Chemistry|February 1, 1983
Buspirone analogues. 1. Structure-activity relationships in a series of N-aryl- and heteroarylpiperazine derivativesJ P Yevich, D L Temple, J S New, et al.
Life Sciences|January 1, 1991
Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatmentF D Yocca, A S Eison, D K Hyslop, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1994
BMY 14802, a sigma receptor ligand for the treatment of schizophreniaG R Gewirtz, J M Gorman, J Volavka, et al.
Australian Veterinary Journal|May 13, 2016
Piroxicam and doxycycline treatment for an oral squamous cell carcinoma in an inshore bottlenose dolphin (Tursiops aduncus)D T March, D J Blyde, G D Bossart, et al.
Psychopathology|January 1, 1984
Neuropharmacology of buspironeL A Riblet, A S Eison, M S Eison, et al.
Biotechnology and Bioengineering|November 1, 1983
Hollow-fiber membrane bioreactors using immobilized E. coli for protein synthesisD S Inloes, W J Smith, D P Taylor, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Antibiotics|May 1, 1986
A cryptic plasmid from Nocardia orientalis NRRL 2452, a vancomycin producerY K Oh, L R Fare, D P Taylor, et al.
Australian Veterinary Journal|June 28, 2017
Long-term control of olfactory neuroblastoma in a dog treated with surgery and radiation therapyE Gumpel, A S Moore, D J Simpson, et al.
The Journal of Antibiotics|April 1, 1993
Screening microbial metabolites for new drugs--theoretical and practical issuesG G Yarbrough, D P Taylor, R T Rowlands, et al.
Applied and Environmental Microbiology|July 1, 1983
Ethanol Production by Saccharomyces cerevisiae Immobilized in Hollow-Fiber Membrane BioreactorsD S Inloes, D P Taylor, S N Cohen, et al.
Journal of Medicinal Chemistry|February 1, 1983
Buspirone analogues. 1. Structure-activity relationships in a series of N-aryl- and heteroarylpiperazine derivativesJ P Yevich, D L Temple, J S New, et al.
Life Sciences|January 1, 1991
Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatmentF D Yocca, A S Eison, D K Hyslop, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1994
BMY 14802, a sigma receptor ligand for the treatment of schizophreniaG R Gewirtz, J M Gorman, J Volavka, et al.
Australian Veterinary Journal|May 13, 2016
Piroxicam and doxycycline treatment for an oral squamous cell carcinoma in an inshore bottlenose dolphin (Tursiops aduncus)D T March, D J Blyde, G D Bossart, et al.
Psychopathology|January 1, 1984
Neuropharmacology of buspironeL A Riblet, A S Eison, M S Eison, et al.
Biotechnology and Bioengineering|November 1, 1983
Hollow-fiber membrane bioreactors using immobilized E. coli for protein synthesisD S Inloes, W J Smith, D P Taylor, et al.
Pageof 9